What Is a Home Care Business Worth in 2026? A Valuation Guide for Owners
Home-based-care dealmaking came back to life in early 2026, and home care owners are asking a fair question: what is my business actually worth right now? In the first quarter of 2026, 22 home-based-care transactions closed, a return to pre-pandemic deal levels, and non-medical home care led the non-hospice sub-sectors with nine of those deals (Mertz Taggart, Q1 2026). The quarter’s headline transaction, Kinderhook Industries acquiring Enhabit Home Health and Hospice for about $1.1 billion at a 10.2x EBITDA multiple, set the tone at the platform end of the market. For the typical owner-operated agency, the numbers are smaller and the lesson is sharper: non-medical home care trades at roughly 5.0x to 8.0x EBITDA, and the difference between the low end and the high end is mostly within your control.
This guide explains how a home care business valuation works in 2026, what multiple home care agencies sell for, and the specific levers that move your number. As of June 2026, buyers are active but disciplined, so preparation is the clearest path to a stronger outcome. Vallexa Advisors is a healthcare-only M&A advisory firm, and we work only in home health, hospice, and home care, so every figure below is framed for an owner like you rather than a generic small business.
What is a home care business worth in 2026?
A home care business is generally worth a multiple of its adjusted earnings, and for non-medical home care that multiple sits around 5.0x to 8.0x EBITDA as of June 2026, with smaller agencies lower and scaled platforms higher. A home care business valuation is the process of estimating that figure by normalizing your earnings, applying a market multiple, and adjusting for the risks and strengths a buyer sees in your specific agency. The result is a range, not a single fixed price, because the final number depends on payer mix, caregiver retention, owner dependency, geography, and how clean your financial records are.
For context, non-medical personal care remains the highest-volume segment in home-based-care M&A while trading at the lowest multiples, mainly because of its labor intensity and Medicaid-heavy payer mix in many markets. Medicare-certified skilled home health and hospice tend to command higher multiples on more predictable, clinically driven revenue. That gap is not a verdict on your business. It is a starting point, and the rest of this guide is about closing the distance between an average outcome and a strong one.
How are home care businesses valued?
Home care businesses are valued primarily on adjusted earnings, using either Seller’s Discretionary Earnings (SDE) for smaller owner-run agencies or EBITDA for larger ones, multiplied by a market multiple. The method matters because it changes the math. SDE adds the owner’s salary, benefits, and one-time costs back into profit, which suits a single-location agency where the owner is deeply involved. EBITDA (earnings before interest, taxes, depreciation, and amortization) assumes a replacement manager is already paid for, which is how buyers underwrite larger or multi-site operations.
Most buyers start with a revenue rule of thumb to screen deals, then pivot to earnings at the letter-of-intent stage. Revenue multiples for smaller home care practices are crude, often in the range of 0.5x to 1.0x of annual revenue, and they exist mainly to filter opportunities quickly. The real price gets set on earnings. That is why two agencies with identical revenue can be worth very different amounts: the one with cleaner books, higher margins, and documented add-backs converts more of its top line into the earnings a buyer will actually pay a multiple on.
Add-backs are where many owners leave money on the table. Personal vehicle costs, owner travel, family members on payroll above market rate, one-time legal fees, and discretionary spending can legitimately be added back to earnings, but only if you can document them. As of June 2026, buyers are scrutinizing add-backs more closely than they did two years ago, so a clean, defensible schedule is worth real multiple points.
What EBITDA multiple do home care agencies sell for in 2026?
Home care agencies sell for roughly 3.0x to 10.0x EBITDA in 2026 depending on size, with most owner-operated non-medical agencies landing in the 5.0x to 8.0x range and scaled platforms reaching higher. Size is the single clearest driver because larger agencies carry less risk per dollar of earnings: more caregivers, more referral sources, more management depth, and less dependence on any one person. The table below shows how multiples typically scale, and the ranges depend on payer mix, geographic footprint, staff retention, and referral relationships rather than size alone.
| Agency profile (non-medical home care) | Typical EBITDA multiple (2026) | Most likely buyer |
|---|---|---|
| Small, single-market (under ~$500K EBITDA) | 3.0x to 5.0x | Local operator, individual buyer, small add-on |
| Regional operator (~$0.5M to $2M EBITDA) | 5.0x to 8.0x | Sponsor-backed add-on, regional consolidator |
| Scaled multi-market platform (>~$2M EBITDA) | 7.0x to 10.0x | Private equity platform, strategic acquirer |
For cross-sector context, hospice continues to command the highest multiples in home-based care on census stability and predictable length of stay, and Medicare-certified home health typically trades higher than non-medical private duty. The Enhabit transaction at 10.2x EBITDA reflects platform-scale, diversified pricing, not what a single-location private-pay agency should expect. Use the platform numbers as a direction of travel, not a personal benchmark, and anchor your own expectations to the size tier you actually occupy today.
What drives a home care agency’s valuation multiple?
A home care agency’s multiple is driven mostly by risk: the lower a buyer’s perceived risk, the higher the multiple they will pay. Buyers do not pay for hype. They pay for proof, which means clean books, dependable billable hours, diversified referrals, and a team that runs without the owner. Every value driver below either reduces a buyer’s risk or raises it, and the gap between a well-run agency and an average one is usually two to three turns of EBITDA.
| Raises your multiple | Lowers your multiple |
|---|---|
| Strong private-pay share and diversified payers | Heavy single-payer concentration (one Medicaid program or one contract) |
| Caregiver turnover below the industry norm | Turnover near or above ~79% industry average |
| Management team that runs daily operations | Owner is the main scheduler, recruiter, and referral source |
| Diversified, documented referral relationships | One or two referral sources drive most volume |
| Clean financials with documented add-backs | Commingled personal and business spending, no audit trail |
| Stable or growing billable hours and census | Declining hours or unfilled authorized cases |
| Clear compliance and accreditation history | Open survey deficiencies or billing audit exposure |
The pattern across these factors is consistency. A buyer is purchasing future cash flow, so anything that makes your future hours more predictable raises the price, and anything that makes them uncertain pulls it down. Profitability pressure has become the fastest-rising concern in the sector, cited by 34% of agencies in 2026 compared with 13% earlier, driven by wages, tighter Medicaid reimbursement, and compliance cost (industry trend data, 2026). Agencies that have protected margin against that pressure stand out, and they get paid for it.
How does payer mix affect home care value?
Payer mix is the single largest driver of a home care agency’s multiple, because it determines both margin and the durability of your revenue. A higher share of private-pay clients generally supports a higher multiple, since private pay carries better rates, fewer authorization constraints, and less reimbursement risk than Medicaid waiver programs. As of June 2026, private-pay home care rates sit around $33 to $34 per hour, and agencies with a healthy private-pay base convert more of each hour into margin a buyer can underwrite.
This does not mean Medicaid HCBS volume is bad. Medicaid Home and Community-Based Services provide stable, recurring demand and meaningful scale, and many strong agencies are built on it. The risk a buyer prices in is concentration. If one Medicaid program or a single managed-care contract drives most of your revenue, your multiple absorbs that single point of failure. A blended book of private pay, Medicaid HCBS, long-term care insurance, and Veterans Affairs cases reads as lower risk, and lower risk is what earns the upper half of the range.
Does caregiver turnover lower my valuation?
Yes, high caregiver turnover lowers your valuation, because it signals unfilled hours, rising recruitment cost, and fragile service delivery to a buyer. Industry turnover has been running near 79%, and replacing a single caregiver costs roughly $2,600 to $5,000 once recruiting, onboarding, and lost hours are counted (industry data, 2026). For a mid-sized agency, that can total well over $200,000 a year spent simply holding staffing steady, and a buyer reads that as a direct drag on future earnings.
The reassuring part is that retention is one of the most provable strengths you can show. Demand for caregivers is durable: home health and personal care aides are the largest occupation in the United States at roughly 4.0 million workers, with employment projected to grow 17% through 2034, much faster than average (U.S. Bureau of Labor Statistics). An agency that recruits and retains caregivers efficiently in that environment owns a scarce capability, and buyers pay a premium for it. Track your turnover rate, fill rate, and time-to-fill, and bring those numbers to the table.
How do I increase my home care business value before a sale?
You increase your home care business value by reducing the risks a buyer prices in, ideally 12 to 24 months before you go to market. Most owners come to us six to nine months later than they should, and there is almost always still time to fix the highest-impact items. The steps below are ordered by how much they typically move the multiple.
- Clean up your financials and document add-backs. Separate personal from business spending, produce clear monthly statements, and build a defensible add-back schedule. This is the cheapest multiple you will ever buy.
- Shift payer mix toward private pay. Grow private-pay and long-term care insurance volume to dilute single-payer concentration and lift blended margin.
- Cut caregiver turnover. Improve scheduling, pay competitiveness, and recognition, then track the turnover and fill-rate numbers that prove it to a buyer.
- Reduce owner dependency. Put a manager in charge of scheduling, recruiting, and key referral relationships so the agency clearly runs without you.
- Diversify referral sources. Broaden beyond one or two hospitals, case managers, or facilities so no single relationship can swing your volume.
- Tighten compliance and accreditation. Close survey deficiencies, keep documentation audit-ready, and maintain accreditation where it applies to your market.
- Get a baseline valuation early. Establish your current range now so you can measure progress and time the market with real numbers rather than a guess.
None of these require a dramatic overhaul. They require a plan and a head start. An agency that walks into a process with clean books, a diversified payer base, low turnover, and a functioning management team can credibly argue for the top of its size tier rather than the bottom.
Should I sell my home care business now or wait?
Whether to sell now or wait depends on your readiness and your goals more than on timing the market perfectly, but the current window is favorable for prepared sellers. As of June 2026, deal volume has returned to pre-pandemic levels and buyers are active, in part because private equity sponsors who have held platforms for five, six, or seven years are under real pressure to return capital to their investors. That pressure puts well-prepared add-on and platform candidates in demand, and it tends to reward agencies that show up ready.
Waiting can make sense if your margins, payer mix, or retention need work, since the value you build in the next year may outweigh any shift in market conditions. Selling sooner can make sense if you are ready, fatigued, or want to capture demand while sponsors are active. The honest answer is that the right time is when your business is prepared and your personal goals line up, and the only way to make that call with confidence is to know your current number. The market is not the variable you control. Your readiness is.
Find out what your home care business is worth. Start with a free, confidential range using the ValueMyBusiness valuation calculator, then talk it through with a healthcare-only advisor. Request a free valuation from Vallexa Advisors and we will walk you through your range and the levers that move it. No upfront fees, full confidentiality.
Frequently asked questions about home care business valuation
What is the average multiple for a home care business in 2026?
The average non-medical home care business sells for roughly 5.0x to 8.0x EBITDA in 2026, with small single-market agencies closer to 3.0x to 5.0x and scaled platforms reaching 7.0x to 10.0x. The exact figure depends on payer mix, retention, and how clean your financials are.
How is a home care business valuation calculated?
It is calculated by normalizing your earnings (SDE for smaller agencies, EBITDA for larger ones), then applying a market multiple based on size, payer mix, and risk. Buyers screen on revenue early but set the final price on adjusted earnings.
Is a home care business profitable enough to attract buyers?
Yes, home care attracts steady buyer demand because the underlying need is growing, even though margins are tighter than skilled clinical care. Buyers value durable billable hours and efficient caregiver recruitment more than headline revenue.
Does payer mix really change my valuation that much?
Yes, payer mix is the single largest driver of a home care multiple because it sets both your margin and your revenue durability. A diversified book with healthy private pay generally earns the upper half of the range.
How long does it take to sell a home care business?
A confidential sale process commonly runs about six to nine months from preparation to close, depending on diligence and licensing transfer. Starting your preparation 12 to 24 months ahead gives you time to raise the value first.
What is the difference between SDE and EBITDA for home care?
SDE adds the owner’s full compensation and discretionary costs back to profit and suits small owner-run agencies, while EBITDA assumes a paid replacement manager and is used for larger operations. The method changes which multiple applies.
Will high caregiver turnover stop a sale?
High turnover rarely stops a sale outright, but it lowers the multiple and can trigger price adjustments in diligence. Showing improving retention metrics before you go to market protects your value.
Can I get a valuation without committing to sell?
Yes, a confidential baseline valuation carries no obligation to sell and is the best way to plan. Knowing your range early lets you decide whether to go now or build value first.
About the author
Jason Atty is the founder of Vallexa Advisors, a healthcare-only M&A advisory firm focused exclusively on home health, hospice, and home care. Jason and the Vallexa team advise agency owners on valuation, pre-sale preparation, and confidential sale processes, working on 100% success-based fees with no upfront cost. Vallexa operates a nationwide buyer network and an NDA-gated process that keeps an owner’s identity confidential until a qualified buyer is vetted. The firm’s perspective is built from real transactions in home-based care, which is why every valuation discussion starts with your numbers rather than a generic template.
Ready to know your number? Run a free range on the ValueMyBusiness calculator, then start a confidential conversation with Vallexa Advisors. We will help you read your valuation, prioritize the levers that raise it, and decide whether now or later is the right time to sell. You can also review our 7 steps to selling to see exactly how a confidential process runs.
Related resources
- Home health agency valuation guide for owners of Medicare-certified skilled agencies.
- Hospice valuation multiples guide for hospice owners weighing a sale.
- ValueMyBusiness calculator for a fast, free valuation range.
- Exits.ai for anonymous buyer demand, and ExitStrategies.com for exit timing and succession planning.
Sources
- Mertz Taggart, Q1 2026 Home-Based Care M&A Report, 2026.
- McKnight’s Home Care, “Home care M&A rebounds in Q1, marking return to prepandemic levels,” 2026.
- Home Health Care News, “Inside the Risk and Reward Calculus Driving M&A in Home-Based Care,” 2025.
- U.S. Bureau of Labor Statistics, Home Health and Personal Care Aides, Occupational Outlook Handbook, 2026.
- Home Care Association of America (HCAOA), industry resources, 2026.
Educational only. Not legal, financial, or tax advice. Healthcare M&A outcomes depend on specific facts, payer mix, market conditions, and regulatory context. Speak with qualified counsel before acting on anything in this document.
Key Takeaways
- Home care business valuation in 2026 typically ranges from 5.0x to 8.0x EBITDA for non-medical agencies, depending on size and risk factors.
- Buyers prioritize adjusted earnings and scrutinize financial records, focusing on clean books and documented add-backs to determine valuation multiples.
- A diversified payer mix boosts valuation, with higher shares of private-pay clients generally supporting better margins and lower risk.
- High caregiver turnover negatively impacts valuation, signaling potential service delivery issues and increased recruitment costs.
- Preparing your home care business for sale involves improving financials, retention, and management dependence to command a higher multiple.
Estimated reading time: 13 minutes
